1004759-91-4

Upstream product

• 108052-76-2 4-(bromomethyl)benzoic acid 1,1-dimethylethyl ester 
• 124-40-3 dimethyl amine 
• 65874-27-3 4-(tert-butoxycarbonyl)benzaldehyde 
• 619-66-9 4-Carboxybenzaldehyde 

Downstream Products

• 1004759-63-0 N-(4'-tert-butoxycarbonylbenzyl)-N,N-dimethyl-N-[(-)-8-phenylmenthoyloxycarbonylmethyl]ammonium bromide 
• 1259324-75-8 N-(4-tert-butoxycarbonyl)benzyl-N,N-dimethyl-2-oxo-2-(pyrrolidin-1-yl)ethanammonium bromide 
• 1259324-79-2 N-(4-tert-butoxycarbonyl)benzyl-N-(2-n-butylamino-2-oxo)ethyl-N,N-dimethylammonium bromide 
• 18364-71-1 4-((dimethylamino)methyl)benzoic acid 

Relevant academic research and scientific papers

DIAZANAPHTHALEN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF

Diazanaphthalene compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of a diazanaphthalene compound or analogs thereof, in the treatment of disorders characterized by the activa

18/19F-LABELLED COMPOUNDS WHICH TARGET THE PROSTATE SPECIFIC MEMBRANE ANTIGEN

This disclosure relates to novel compounds comprising a zwitterionic trifluoroborate prosthetic group which target prostate-specific membrane antigen (PSMA), e.g. in prostate cancer. The compounds have Formula I, wherein each Rl is an anionic group, L is

Asymmetric Sommelet-Hauser rearrangement of N-benzylic ammonium salts

(Chemical Equation Presented) [2,3] over [1,2]: The asymmetric Sommelet-Hauser rearrangement of an ammonium salt derived from N-benzylic proline-derived or N-benzylic glycine (-)-8-phenylmenthol ester is shown to proceed with remarkably high levels of stereoselectivity. The method provides unique and efficient access to optically active α-aryl amino acid derivatives.